Fatty liver due to high levels of serum tacrolimus after liver transplantation

Turkish Journal of Pediatrics

Volumn 49, Issue 2, 2007, Pages 223-225

  Tümgör, Gökhan ^a   Arikan, Çigdem ^a   Nart, Deniz ^a   Kiliç, Murat ^b   Aydoǧdu, Sema ^a  

^a EGE UNIVERSITY   (Turkey)

^b Research Center   (Turkey)

Author keywords

Fatty liver; Liver transplantation; Tacrolimus

Indexed keywords

TACROLIMUS;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALOPECIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD ANALYSIS; BODY MASS; CASE REPORT; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; ECHOGRAPHY; FATTY LIVER; FEMALE; GASTROENTERITIS; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HOSPITALIZATION; HUMAN; INCIDENCE; INFECTION; INTRAHEPATIC CHOLESTASIS; KIDNEY DISEASE; LIVER BIOPSY; LIVER TRANSPLANTATION; NEUROLOGIC DISEASE; PRESCHOOL CHILD; PRURITUS; ROTAVIRUS; SIDE EFFECT;

BIOPSY; CHILD, PRESCHOOL; FATTY LIVER; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; TACROLIMUS;

EID: 34548118825     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. European FK506 Multicenter Liver Study Group. Randomized trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. Lancet 1994; 344: 423-428.
2. Smith JM, Nemeth TL, McDonald RA. Current immunosuppressive agents: efficacy, side effects, and utilization. Pediatr Clin North Am 2003; 6: 1283-1300.
3. Hochleitner BW, Bosmuller C, Nehoda H, et al. Increased tacrolimus levels during diarrhea. Transpl Int 2001; 14: 230-233.
4. Fruthwirth M, Fischer H, Simma B, et al. Rotavirus infection as cause of tacrolimus elevation in solid organ transplanted children. Pediatr Transplant 2001; 5: 88-92.
5. Eades SK, Boineau FG, Christensen ML. Increased tacrolimus levels in a pediatric renal transplant patient attributed to chronic diarrhea. Pediatr Transplant 2000; 4: 63-60.
6. Hebert MF. Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery. Adv Drug Delivery Rev 1997; 27: 201-214.
7. Marchetti P, Navalesi R. The metabolic effects of cyclosporin and tacrolimus. J Endocrinol Invest 2000; 23: 482-490.
8. Kanwar SS, Singh V, Malik K, et al. Hepatic involvement in rotavirus gastroenteritis in a homologous murine model. Immunol Infect Dis 1993; 3: 77-81.
9. Gilger MA, Matson DO, Conner ME, et al. Extraintestinal rotavirus infection in children with immunodeficiency. J Pediatr 1991; 120: 912-917.
10. Ee L. Rotavirus, hepatitis and Reye syndrome. J Paediatr Child Health 2002; 38: 533.
11. El-Youssef M, Freese DK. Systemic conditions affecting the liver. In: Walker WA, Goulet O, Kleinman RE, Sherman PM, Shneider BL, Sanderson IR (eds). Pediatric Gastrointestinal Disease (4th ed) Vol. 2. Ontario: BC Decker Inc; 2004: 1466-1490.